Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar)

Aquaculture

Volumn 238, Issue 1-4, 2004, Pages 51-66

  Coyne, Rosie ^a   Bergh, Øivind ^a   Samuelsen, Ole ^a   Andersen, Kari ^a   Lunestad, Bjørn Tore ^a   Nilsen, Hanne ^b   Dalsgaard, Inger ^c   Smith, Peter ^d  

^a INSTITUTE OF MARINE RESEARCH   (Norway)

^b NORWEGIAN VETERINARY INSTITUTE   (Norway)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Antimicrobial therapy; MIC; Oxolinic acid; Salmon; Tissue concentrations

Indexed keywords

AQUACULTURE; DISEASE CONTROL; SALMONID;

BACTERIA (MICROORGANISMS); SALMO; SALMO SALAR;

EID: 4344644732     PISSN: 00448486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquaculture.2004.04.027     Document Type: Article

References (34)

1. Alderman D., Smith P. Development of draft protocols of standard reference methods for antimicrobial agent susceptibility testing of bacteria associated with fish disease. Aquaculture. 196:2001;211-243
2. AliAbadi F.S., Lees P. Antibiotic treatment for animals: effect on bacterial population dosage regimen optimisation. Int. J. Antimicrob. Agents. 14:2000;307-313
3. Aoyama R., McErlane E., Erber H. High performance liquid chromatographic analysis of oxytetracycline in chinook salmon following administration of medicated feed. J. Chromatogr. 588:1991;181-186
4. Austin B., Austin D.A. Bacterial Fish Pathogens; Disease in Farmedwild Fish. 1993;Ellis Horwood, Chichester
5. Barnes A.C., Hastings T.S., Amyes S.G.B. Aquaculture antibacterial are antagonised by seawater cations. J. Fish Dis. 18:1995;463-465
6. Benediktsdottir E., Verdonck L., Sproer C., Helgason S., Swings J. Characterization of Vibrio viscosus and Vibrio wodanis isolated at different geographical locations: a proposal for reclassification of Vibrio viscosus as Moritella viscosa comb. nov. Int. J. Syst. Evol. Microbiol. 50:2000;479-488. (Part 2 MAR 2000)
7. Bjørklund H., Bylund G. Comparative pharmacokineticsbioavailability of oxolinic acidoxytetracycline in rainbow trout (Oncorhynchus mykiss). Xenobiotica. 21:1991;1511-1520
8. BSAC. A guide to sensitivity testing. Report of the working party on antibiotic sensitivity testing of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother. 23:(Suppl. D):1991;1-47
9. Ellingsen O.F., Midttun B., Rogstad A., Syvertsen C., Samuelsen O.B. Dosage regime experiments with oxolinic acid flumequine in Atlantic salmon (Salmo salar L.) held in seawater. Aquaculture. 209:2002;19-34
10. Gyssens I.C. Quality measures of antimicrobial drug use. Int. J. Antimicrob. Agents. 17:2001;9-19
11. Hustvedt S.O., Salte R., Vassvik V. Absorption, distribution elimination of oxolinic acid in Atlantic salmon (Salmo salar L.) after various routes of administration. Aquaculture. 95:1991;193-199
12. Hustvedt S.O., Salte R., Kvendset O., Vassvik V. Bioavailability of oxolinic acid in atlantic salmon (Salmo salar L.) from medicated feed. Aquaculture. 97:1991;305-310
13. Hustvedt S.O., Salte R., Vassvik V. Combatting cold water vibriosis in Atlantic salmon (Salmo salar L.) with oxolinic acid: a case report. Aquaculture. 103:1992;213-219
14. Ishida N. Tissue levels of oxolinic acid after oral or intravascular administration to freshwater and seawater rainbow trout. Aquaculture. 102:1992;9-15
15. Kleinow K.M., Jarboe K.E., Shoemaker K.E., Greenlees K.J. Comparative pharmacokinetics and bioavailability of oxolinic in channel catfish (Ictalurus punctatus) rainbow trout (Oncorhynchus mykiss). Can. J. Fish Aquat. Sci. 51:1994;1205-1211
16. Lunder T., Evensen O., Holstad G., Hastein T. Winter ulcer in the Atlantic salmon Salmo salar. Pathological and bacteriological investigations and transmission experiments. Dis. Aquat. Org. 23:1995;39-49
17. NCCLS. Disk diffusion susceptibility testing protocols for antimicrobials used for aquatic species isolates; A report. NCCLS Document M42-R. 2003;NCCLS, Wayne, Pennsylvania, USA
18. NicGabhainn, S., Amedeo, M., Bergh, O., Dixon, B., Donachie, L., Carson, J.R., Coyne, R., Curtin, J., Dalsgaard, I., Maxwell. G., Smith, P., in press. The precision and robustness of published protocols for disc diffusion assays of antimicrobial agent susceptibility: an inter-laboratory study. Aquaculture.
19. Nordmo R., Riseth J.M., Varma K.J., Sutherland I.H., Brokken E.S. Evaluation of florfenicol in Atlantic salmon, Salmo salar L.: efficacy against furunculosis due to Aeromonas salmonicida and cold water vibriosis due to Vibrio salmonicida. J. Fish Dis. 21:1998;289-297
20. O'Grady P., Smith P. Clinical significance of low levels of resistance to oxolinic acid in Aeromonas salmonicida. Bull. Eur. Assoc. Fish Pathol. 12:1992;198-200
21. Piddock L. Techniques used for the determination of antimicrobial resistance and sensitivity in bacteria. J. Appl. Bacteriol. 68:1990;307-318
22. Rogstad A.V., Ellingsen O.F., Syvertsen C. Pharmacokinetics and bioavailability of flumequine and oxolinic acid after various routes of administration to Atlantic salmon in seawater. Aquaculture. 110:1993;207-220
23. Samuelsen O.B. Simple and rapid method for the determination of flumequine and oxolinic acid in salmon (Salmo salar) plasma by high-performance liquid-chromatography and fluorescence detection. J. Chromatogr. Biomed. Appl. 530:1990;452-457
24. Samuelsen O.B., Lunestad B.T., Husevåg B.T., Hølleland T., Ervik A. Residues of oxolinic acid in wild fauna following medication in fish farms. Dis. Aquat. Org. 12:1992;111-119
25. Samuelsen O.B, Hjeltnes B., Torkildsen L. Efficacy of orally administered oxolinic acid and Vetoquinol, an oxolinic acid ester, for the treatment of furunculosis in Atlantic salmon Salmo salar held in seawater. Dis. Aquat. Org. 37:1999;53-59
26. Samuelsen O.B., Ervik A., Pursell L., Smith P. Single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in Atlantic salmon (Salmo salar) held in seawater and in-vitro activity against Aermonas salmonicida. Aquaculture. 187:2000;213-224
27. Siegel B.F. Non-Parametric Statistics. 1956;McGraw-Hill, New York
28. Sirot J., Courvalin P., Soussy C. Definition determination of in-vitro antibiotic susceptibility breakpoints for bacteria. Clin. Microbiol. Infect. 2:(Supplement 1):1996;S5-S10
29. Smith P. Towards the establishment of a breakpoint concentration for the determination of resistance to oxolinic acid in marine microflora. Aquaculture. 161:1998;229-239
30. Smith P. Accuracy, precision and meaning of antimicrobial agent susceptibility testing of bacteria associated with fish diseases. Aquaculture. 196:2001;253-266
31. Smith P., Hiney M.P., Samuelsen O.B. Bacterial resistance to antimicrobial agents used in fish farms; a critical evaluation of method and meaning. Annu. Rev. Fish Dis. 4:1994;273-313
32. Stamm J.M. In vitro resistance by fish pathogens to aquacultural antibacterials, including the quinolones difloxacin (A-56619) and sarafloxacin (A-56620). J. Aquat. Anim. Health. 1:1989;135-141
33. Stoffregen D.A., Bowser P.R., Babish J.G. Antibacterial chemotherapeutants for fin-fish aquaculture: a synopsis of laboratory and field efficacy studies. J. Aquat. Anim. Health. 83:1996;181-207
34. Tsoumas A., Alderman D.J., Rodgers C.J. Aeromonas salmonicida: development of resistance to 4-quinolone antimicrobials. J. Fish Dis. 12:1989;493-507